Cargando…
Alendronate Inhibits VEGF Expression in Growth Plate Chondrocytes by Acting on the Mevalonate Pathway
Bisphosphonates decrease chondrocyte turnover at the growth plate and impact bone growth. Likewise vascular endothelial growth factor (VEGF) plays an important role in endochondral bone elongation by influencing chondrocyte turnover at the growth plate. To investigate whether the action of bisphosph...
Autores principales: | Evans, K.D, Oberbauer, A.M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761671/ https://www.ncbi.nlm.nih.gov/pubmed/19834579 http://dx.doi.org/10.2174/1874325000903010083 |
Ejemplares similares
-
Alendronate, a double-edged sword acting in the mevalonate pathway
por: TRICARICO, PAOLA MAURA, et al.
Publicado: (2015) -
Weekly oral alendronate in mevalonate kinase deficiency
por: Cantarini, Luca, et al.
Publicado: (2013) -
Regulation of VEGF by mevalonate pathway inhibition in breast cancer
por: Rachner, Tilman D., et al.
Publicado: (2013) -
Fibroblast growth factor receptor 3 effects on proliferation and telomerase activity in sheep growth plate chondrocytes
por: Smith, Logan B, et al.
Publicado: (2012) -
Inhibition of the mevalonate pathway improves myocardial fibrosis
por: Xu, Huifeng, et al.
Publicado: (2021)